X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Frontiers in Oncology

期刊標題檢索 FRONT ONCOL 最新評論: One reviewer agreed to publish, while another rejected. Finally, in th... (2024-10-29)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Frontiers in Oncology]您好,您是該頁面的第 415873 位訪客。

期刊簡介
期刊名稱Frontiers in Oncology Frontiers in Oncology
LetPub Score
7.3
56 ratings
Rate

Reputation
7.4

Influence
6.5

Speed
8.4

期刊簡稱FRONT ONCOL
ISSN2234-943X
h-index60
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.201.0660.831
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q2120 / 404
Category: Medicine
Subcategory: Cancer Research
Q2100 / 230

自引率 (2023-2024)5.70%自引率趨勢
掲載範囲
Cancer Imaging and Diagnosis is dedicated to the publication of results from clinical and research studies applied to cancer diagnosis and treatment. The section aims to publish studies from the entire field of cancer imaging: results from routine use of clinical imaging in both radiology and nuclear medicine, results from clinical trials, experimental molecular imaging in humans and small animals, research on new contrast agents in CT, MRI, ultrasound, publication of new technical applications and processing algorithms to improve the standardization of quantitative imaging and image guided interventions for the diagnosis and treatment of cancer.
官方網站https://www.frontiersin.org/journals/oncology
在線稿件提交https://www.frontiersin.org/journals/oncology#author-guidelines
開放訪問Yes
出版商Frontiers Media S.A.
主題領域Biochemistry, Genetics and Molecular Biology
出版國/地區Switzerland
發行頻率
創刊年0
每年文章數4475每年文章數趨勢
黃金OA百分比99.56%
OA Related Info
APC: Yes( USD3295; )
APC waiver:Check Notes
Other charges: No
Keywords: cancer research、clinical oncology、cancer genetics、molecular targets、surgical oncology
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ2107/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2234-943X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 14 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Frontiers in Oncology】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Cancer CommunicationsH-index: 0

    CiteScore: 25.50
    CELLULAR ONCOLOGYH-index: 0

    CiteScore: 10.30
    Translational OncologyH-index: 41

    CiteScore: 8.40
    Journal of Gastric CancerH-index: 22

    CiteScore: 4.30
    Molecular and Cellular OncologyH-index: 0

    CiteScore: 3.20
    Clinical and Experimental MorphologyH-index: 0

    CiteScore: 0.60
    Critical Reviews in OncogenesisH-index: 0

    CiteScore: 1.70
    International Journal of Medical BiochemistryH-index: 0

    CiteScore: 0.50
    Advances in Cancer Biology MetastasisH-index: 0

    CiteScore: 2.40
    學科內最受檢索的期刊 頁面查看次數
    Translational Oncology65725
    Cancer Communications55528
    CELLULAR ONCOLOGY31534
    Journal of Gastric Cancer16501
    Molecular and Cellular Oncology4958
    Critical Reviews in Oncogenesis3599
    Clinical and Experimental Morphology2582
    Advances in Cancer Biology Metastasis758
    International Journal of Medical Biochemistry628
  •  

    Frontiers in Oncology Frontiers in Oncology
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/143)
  [Frontiers in Oncology] 的評論撰寫評論
作者: 123


領域: 医学
審稿時間: 3.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-29 15:12:09 評論於
One reviewer agreed to publish, while another rejected. Finally, in the editor module, the reasons for rejection were understood and modifications were made. It has been showing "review is ongoing" for two weeks without any changes. Does this mean rejection?
(0) 讚! | 123

作者: 墟散云泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-29 09:40:12 評論於
I hope he endorses too.
(0) 讚! | 墟散云泽

作者: 西域鹏云


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-28 20:26:45 評論於
Trashy magazines, submitted two articles, one has been waiting for almost four months without being assigned an editor, no response to emails, the other is even worse, after submitting for half a year, the comments from reviewers gradually came back, with one rejecting and two agreeing to publish after major revisions. I thought it would go smoothly, but after waiting for over a month for the associate editor to make a decision, I received a replacement for no reason. The new associate editor took over and another month passed, only to be ultimately rejected, with the reason being that the reviewers' comments were superficial and the article had no value. I am truly frustrated, he made hundreds of patients' cases seem worthless. I will never submit again, and the magazine that is dragging its feet on assigning editors is also withdrawing submissions.
(0) 讚! | 西域鹏云

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-24 22:51:28 評論於
It has been a month since the editorial assignment was given, but editors have not been assigned yet. Despite reminders through emails, there has been no progress, which is causing concern. They are taking too long to take action.
(0) 讚! | Adelaide Lawson

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-23 12:28:20 評論於
Please be patient. It seems that everything is moving slowly. Mine has also been two months.
(0) 讚! | Adelaide Lawson

作者: 仙灵佳惠


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-22 14:50:42 評論於
I also submitted my article in June, and I have only received one review so far. Is it really this slow?
(0) 讚! | 仙灵佳惠

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-12 09:20:34 評論於
Submission success rate: 50.0
Experience sharing: In August, I submitted my work and received feedback from a total of 2 reviewers, both of whom provided some suggestions. However, it is worth noting that they did not recommend rejection. The system does not show whether the work has been finalized or rejected. Currently, it is undergoing the third round of review by another reviewer.
(1) 讚! | Adelaide Lawson

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-10 22:44:05 評論於
Review speed: 3.0 Experience sharing: Just a note: I submitted my manuscript on June 20th, and it has been over three months now. In August, one of the reviewers has finished their review, but currently it still says "review is ongoing." Anyone had a similar experience? Let's chat.
(0) 讚! | Adelaide Lawson

作者: Mildred Harvey


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-10 19:40:21 評論於
Brother, if the email is private, there is no need to pay attention to them.
(0) 讚! | Mildred Harvey

作者: 西域鹏云


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-07 10:52:06 評論於
I have been waiting for over three months and still have not been assigned an editor. I have sent emails but have not received any response.
(0) 讚! | 西域鹏云

作者: 黑山友梅


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-01 09:37:36 評論於
He is a scammer, I also received the email but did not pay, and also reported it.
(0) 讚! | 黑山友梅

作者: 应龙冰珍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-28 14:50:09 評論於
Will we be kicked, everyone?
(0) 讚! | 应龙冰珍

作者: u


領域: 医学
審稿時間: 3.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-22 11:13:54 評論於
It has been three months, Reviewer 1 completed their review two months ago, why is the review still ongoing? ?
(0) 讚! | u

作者: Gustave Coverdale


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-18 19:39:25 評論於
I am too.
(0) 讚! | Gustave Coverdale

作者: 萦思桑


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-18 16:44:01 評論於
I have also encountered a similar article. It was a case where the patient reported had passed away. It is not known if it was due to this reason. I searched through their entire ethical section, but did not find any mention of this aspect. What was your article about?
(0) 讚! | 萦思桑

作者: 萦思桑


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-18 12:34:24 評論於
Please wait patiently.
(0) 讚! | 萦思桑

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-18 09:57:03 評論於
Review speed: 1.0 | Submission hit rate: 75.0 Emphasized research direction: Oncology Experience sharing: Mine is a review article, with a total of two reviewers invited, one of whom provided revision suggestions. After more than a month of revisions, it was accepted after 1 month and 2 weeks, with a total of 2 months from submission to publication.
(0) 讚! | Adelaide Lawson

作者: Gustave Coverdale


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-18 08:54:13 評論於
Why haven't I found a reviewer after a month? ?
(0) 讚! | Gustave Coverdale

作者: 萦思桑


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-18 08:51:19 評論於
The two articles I received previously were sent to me via email at immunology.editorial.office@frontiersin.org and oncology.production.office@frontiersin.org. The scammer's email address is frontier.editorial.science@gmail.com.
(0) 讚! | 萦思桑

作者: 金山凌昊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-17 20:11:50 評論於
Do you know the reason behind it now?
(0) 讚! | 金山凌昊

作者: 金山凌昊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-17 17:18:23 評論於
How did you resolve it later?
(0) 讚! | 金山凌昊

作者: 金山凌昊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-17 15:01:20 評論於
May I ask if you have figured out the reason behind it?
(0) 讚! | 金山凌昊

作者: 墟散云泽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-16 22:24:33 評論於
Excellent, welcome good luck.
(0) 讚! | 墟散云泽

作者: 萦思桑


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-15 18:00:38 評論於
Have I encountered a scammer? The article has been accepted, although I haven't found it on PubMed yet, but I can see "To view the online publication". On the same day, I received an email from a different address congratulating me on the publication. I replied, and then he told me that his finance was affected by the new crown, and the previous $2095 USD publication fee has not been received. He said it will be refunded next month, and asked me to pay an additional $3,295 USD publication fee within 2 days. I have no money! Comrades, should I reply to him?
(0) 讚! | 萦思桑

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-12 18:34:41 評論於
Good luck, your whole cycle is still very smooth.
(0) 讚! | Adelaide Lawson

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/143)

開始撰寫 [Frontiers in Oncology] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*